WeightWatchers Seeks Bankruptcy Protection to Relieve Debt Load

Published: Wednesday, May 7, 2025 at 12:30 am

WeightWatchers Files for Bankruptcy, Eyes Telehealth Future

WeightWatchers, the iconic weight loss company, is taking a significant step to restructure its finances, announcing on Tuesday that it's seeking Chapter 11 bankruptcy protection. The move aims to alleviate a hefty $1.15 billion debt load and refocus the company on its evolving telehealth services.

The parent company, WW International Inc., revealed that a significant majority of its debt holders (nearly 75%) support the restructuring plan. The company is optimistic about a swift exit from bankruptcy, potentially within 45 days.

Founded over six decades ago, WeightWatchers has navigated recent challenges, including a shift towards the prescription weight loss market. This was highlighted by the 2023 acquisition of Sequence for $106 million, now known as WeightWatchers Clinic. This telehealth service helps users access prescriptions for popular weight loss medications like Ozempic and Wegovy.

Despite the strategic pivot, the company's latest earnings report painted a mixed picture. First-quarter revenue dipped 10%, and the adjusted loss per share was 47 cents. However, a bright spot emerged in clinical subscription revenue, which surged 57% year-over-year, reaching $29.5 million.

The company has also seen leadership changes, with Tara Comonte, a former Shake Shack executive, stepping in as interim CEO following Sima Sistani's resignation in September. Comonte emphasized the company's commitment to providing trusted, science-backed solutions focused on long-term health and community support.

The news sent shares plummeting, trading at under $1 since February and dropping to 39 cents in after-hours trading. The bankruptcy filing was made in the U.S. Bankruptcy Court for the District of Delaware.

BNN's Perspective: This is a pivotal moment for WeightWatchers. While the bankruptcy filing is concerning, the company's focus on telehealth and prescription weight loss medications suggests a willingness to adapt to the changing landscape of health and wellness. The success of this transition will depend on their ability to balance their traditional offerings with this new, potentially lucrative, market. It's a gamble, but one that could ultimately secure the company's future.

Keywords: WeightWatchers, bankruptcy, Chapter 11, debt, telehealth, weight loss, Ozempic, Wegovy, Trulicity, Sequence, WW International Inc., Tara Comonte, Sima Sistani, earnings, revenue, stock, shares, U.S. Bankruptcy Court, District of Delaware, prescription weight loss, weight loss medications, financial restructuring, health and wellness, diet, weight management

Full Story